Camille L Bedrosian - Net Worth and Insider Trading
Camille L Bedrosian Net Worth
The estimated net worth of Camille L Bedrosian is at least $3 Million dollars as of 2024-09-20. Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $3 Million. Details can be seen in Camille L Bedrosian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Camille L Bedrosian has not made any transactions after 2023-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Camille L Bedrosian
Camille L Bedrosian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Camille L Bedrosian owns 4 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Camille L Bedrosian’s form 4 insider trades.
Insider Ownership Summary of Camille L Bedrosian
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | EVP and Chief Medical Officer |
CRNX | Crinetics Pharmaceuticals Inc | 2020-09-01 | director |
ARIA | ARIAD Pharmaceuticals Inc | 2007-04-16 | VP & Chief Medical Officer |
2020-12-09 | director |
Camille L Bedrosian Latest Holdings Summary
Camille L Bedrosian currently owns a total of 1 stock. Camille L Bedrosian owns 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $3 Million.
Latest Holdings of Camille L Bedrosian
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | 46,720 | 58.42 | 2,729,382 |
Holding Weightings of Camille L Bedrosian
Camille L Bedrosian Form 4 Trading Tracker
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 11 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 3,881 shares on March 1, 2023, which brought Camille L Bedrosian around $175,615.
Insider Trading History of Camille L Bedrosian
- 1
Camille L Bedrosian Trading Performance
Camille L Bedrosian Ownership Network
Camille L Bedrosian Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include director & 10 percent owner & President & CEO Emil D Kakkis , Controller and PAO Theodore Alan Huizenga , and EVP and General Counsel Karah Herdman Parschauer .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Camille L Bedrosian made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 40,675 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 40,675 shares. During the past 18 months, 257,334 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 257,334 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Camille L Bedrosian Mailing Address
Above is the net worth, insider trading, and ownership report for Camille L Bedrosian. You might contact Camille L Bedrosian via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.